Target Audience
This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.
Learning Objectives
At the conclusion of this activity, the learner will be better able to:
Identify appropriate indications for ipratropium therapy, including its FDA-approved uses for chronic obstructive pulmonary disease exacerbations and off-label applications such as asthma exacerbations and rhinorrhea.
Implement evidence-based guidelines for ipratropium dosing and administration in chronic obstructive pulmonary disease exacerbations and other respiratory conditions.
Select the most appropriate ipratropium formulation and dosage regimen to tailor treatment plans based on patient characteristics and clinical presentation.
Collaborate with interprofessional healthcare teams, including pharmacists and pulmonologists, to ensure coordinated ipratropium therapy and comprehensive patient care.
Pharmacy Activity Type:
Disease/Drug Therapy Related
Disclosures
StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.
Commercial Support: This activity has received NO commercial support.
- Authors: Preeti Patel
- Editors: Ayham Aboeed
- Editor-in-Chief: Preeti Patel
- Nurse Reviewer: Sandra Coleman
- Pharmacy Reviewer: Mark V. Pellegrini
Continuing Education Accreditation Information
In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-2488-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.
Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.
Method of Participation and Credit
- Register for the activity.
- Review the target audience, learning objectives, and disclosure information.
- Study the educational content of the enduring material.
- Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
- Complete the post-activity assessment survey.
If you have concerns regarding the CE/CME system, please contact support@statpearls.com.
Disclaimer
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.
The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.
Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.
Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.